Meet Elsa Anagnostou at #ISLB24! Valsamo Anagnostou is a translational cancer investigator, focusing on large-scale genomic and liquid biopsy analyses in human cancers. Register Now at 2024.islb.info/z2nz #LiquidBiopsy

📢 Deadlines Extended! Abstract Submission and Late Breaking Abstract Submission Deadlines have been extended to September 3, 2024! This is your final chance to showcase your research at #ISLB24—there won't be any further extensions. Don’t miss this opportunity to present your

Meet Jacob Berchuck at #ISLB24! Dr. Berchuck is a medical oncologist and physician-scientist whose specializes in translational research focused on improving outcomes for people diagnosed with advanced cancer through development of cfDNA-based biomarkers to personalize therapeutic

Meet Silvia Calabuig Fariñas at #ISLB24! Silvia Calabuig is a Permanent Lecturer in the Biology Unit of the Pathology Department at the University of Valencia. She is Head of the Liquid Biopsy Section at the Molecular Oncology Laboratory, eOM Research group at General University

Meet Daniel Chung at #ISLB24! Dr. Daniel Chung is Medical Co-Director of the Center for Cancer Risk Assessment and Director of the High-Risk GI Cancer Clinic at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School.  Register Now at

Meet Luis Diaz at #ISLB24! Dr. Diaz is a pioneer in cancer genomics. His teams were the first to track circulating tumor DNA for the early detection of cancer, tracking resistance and for the detection of minimal residual disease. Register Now at 2024.islb.info/z2nz

Secure your spot at #ISLB24! Whether you attend In Person or choose to access sessions On Demand, this is your chance to engage with the latest innovations and breakthroughs in #LiquidBiopsy. Early registration ends on September 16, so act now to secure your spot and enjoy

Meet Nicola Fusco at #ISLB24! Prof. Nicola Fusco directs the Pathology Division at European Institute of Oncology in Milan, Italy and is an Associate Professor at the University of Milan. Internationally recognized in digital pathology and liquid biopsy diagnostics, his

3 Weeks Left to Submit Your Abstract! The deadline for abstract submission is fast approaching! Don't miss your chance to showcase your research at #ISLB24. Submit by September 3, 2024, at 2024.islb.info/b5dv to be part of the cutting-edge discussions shaping the future of

Meet David Gandara at #ISLB24! David Gandara is a Professor of Medicine Emeritus at the University of California, Davis. He is the co-director of the Center for Experimental Therapeutics in Cancer and Senior Advisor to the Director at UC Davis Comprehensive Cancer Center. Register

⏳ Only 2 weeks left to submit your abstract for #ISLB24! This is your opportunity to showcase your research, connect with leading experts, and contribute to the future of #LiquidBiopsy. Accepted abstracts will be published in The Journal of Liquid Biopsy (JLB), giving your work

Meet Danielle Hicks at #ISLB24! Danielle Hicks is Chief Patient Officer at GO2 Foundation for Lung Cancer and has been working in lung cancer non-profit for the past 16 years. She is responsible for all aspects of patient programming, services, education, engagement, and

Meet Franco Izzo at #ISLB24! Dr. Izzo’s research is focused on applying multi-modal single-cell sequencing technologies to understand how somatic mutations are translated into cellular phenotypes in clonal hematopoiesis and hematological malignancies. Register Now at

One Week Left! 🕒 Time is running out to submit your abstract for #ISLB24! Don’t miss the opportunity to showcase your research and contribute to the future of #liquidbiopsy. The abstract submission deadline is September 3, 2024. Submit now and make your mark at

Meet ELO at #ISLB24! Prof. Eloisa Jantus is an Associate Professor of Cellular Biology in the Department of Biotechnology at the Polytechnic University of Valencia (UPV). She currently serves as a member of the Executive Committee of the International Society of Liquid

📢 Be part of the #ISLB24 Program! Only 5 days left to submit your abstract. Don’t miss the chance to share your research with international experts in #liquidbiopsy. The deadline is September 3, 2024. Submit your work today at 2024.islb.info/b5dv and make an impact!

Last Call! Abstract submission for #ISLB24 ends tomorrow, September 3 (23:59 CEST). ⏳ Don’t miss your opportunity to contribute to the future of #liquidbiopsy. Submit your research now at 2024.islb.info/b5dv and join leading experts in Denver, Colorado, USA, from November

International Society of Liquid Biopsy Last chance to contribute to the future of liquid biopsy! Don't miss the abstract submission deadline tomorrow!

Post-Surgery 🧬🧬🧬ctDNA Detection: A Predictor of Relapse in Early Breast Cancer! #liquid #biopsy #DNA ESMO Open linkinghub.elsevier.com/retrieve/pii/S…

Meet David Kozono at #ISLB24! David Kozono, MD, PhD, is the Director of Thoracic Radiation Oncology at the Dana-Farber Brigham Cancer Center. He is Study Chair of the NCI ALCHEMIST screening protocol for trials of adjuvant therapies for surgically resected NSCLC, and Chair of